Filing Details
- Accession Number:
- 0001062993-21-001199
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-10 19:18:22
- Reporting Period:
- 2021-02-08
- Accepted Time:
- 2021-02-10 19:18:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1616212 | Trillium Therapeutics Inc. | TRIL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1838044 | Penka Petrova | C/O Trillium Therapeutics Inc. 2488 Dunwin Drive Mississauga A6 L5L 1J9 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2021-02-08 | 2,708 | $0.30 | 2,708 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2021-02-08 | 2,604 | $3.31 | 5,312 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2021-02-08 | 5,312 | $12.65 | 0 | No | 4 | S | Direct | |
| Common Shares | Acquisiton | 2021-02-09 | 508 | $9.62 | 508 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2021-02-09 | 508 | $14.17 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Disposition | 2021-02-08 | 2,708 | $0.00 | 2,708 | $0.30 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2021-02-08 | 2,604 | $0.00 | 2,604 | $3.31 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2021-02-09 | 508 | $0.00 | 508 | $9.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 89,376 | 2029-11-07 | No | 4 | M | Direct | |
| 54,688 | 2028-11-08 | No | 4 | M | Direct | |
| 4,574 | 2027-11-09 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7834 USD.
- The exercise price of these options is $4.23 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7834 USD.
- The exercise price of these options is $12.22 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7873 USD.
- 25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.
Billionaire Hedge Funds
